Abbott Fund
Abbott Fund
Abbott Fund
ScienceEd

Abbott Global

Diabetes Education in Bolivia

Share | print

Improving Diabetes Screening, Treatment and Awareness

In Cochabamba, Bolivia’s third-largest city, more than 7 percent of the population suffers from diabetes. Clinica Vivir con Diabetes (CVCD), Abbott Fund’s and Direct Relief International’s local partner, diagnoses and treats patients with diabetes throughout the city while also working to raise awareness through a variety of activities, like the diabetes walk pictured here.

Improving Diabetes Screening, Treatment and Awareness

CVCD held a diabetes awareness fair in a park across the street from its clinic. The event offered free testing and counseling for those found to have Type I or Type II diabetes.

Improving Diabetes Screening, Treatment and Awareness

Many of those tested were young adults from low-income families. CVCD is the region’s only diabetes clinic, delivering care at little or no cost to patients.

Improving Diabetes Screening, Treatment and Awareness

Since 2006, CVCD has screened and cared for 71,000 diabetes patients in Cochabamba, including Type I and Type II diabetes. In addition to our financial support, Abbott donates blood-testing equipment for the clinic as well as for patients’ personal use.

Improving Diabetes Screening, Treatment and Awareness

We also help support CVCD’s lifestyle education courses for diabetes patients. Before CVCD began its educational outreach, health care practitioners in the region tended to treat diabetes as a temporary disease rather than a lifelong condition.

Improving Diabetes Screening, Treatment and Awareness

As part of its mission, CVCD sends trained social workers to visit diabetes patients at home to ensure that they know how to manage their condition.

Improving Diabetes Screening, Treatment and Awareness

Thanks to CVCD, the annual rate of detection of diabetes in Cochabamba has increased by 250 percent. Since 2006, CVCD has served more than 71,000 diabetes patients, counseling them on disease management techniques and healthy living habits.

Improving Diabetes Screening, Treatment and Awareness

RESULTS
System.ArgumentException: Parameter is not valid. at System.Drawing.Bitmap..ctor(Int32 width, Int32 height, PixelFormat format) at System.Drawing.Bitmap..ctor(Image original, Int32 width, Int32 height) at AWS.Imaging.ImageResizer.ResizeAndSaveImage(String imagePath, String resizedImagePath, Int32 maxImageWidth, Int32 maxImageHeight) at AWS.Web.UI.WebControls.ImageDisplay.get_ImageUrl()
Overview
Chronic diseases like diabetes affect a growing number of people in developing nations such as Bolivia, where more than 7 percent of the population now has diabetes. The Abbott Fund is partnering with Direct Relief International to support Clinica Vivir con Diabetes (CVCD) in Cochabamba, the nation's third-largest city. CVCD, a recognized leader in diabetes education, detection and treatment, has trained hundreds of diabetes educators, and identified thousands of diabetes sufferers and referred them for treatment. It is supported by more than $300,000 in grants from the Abbott Fund, plus more than $150,000 in donated products from Abbott. We are also helping CVCD with the ongoing challenge of maintaining and analyzing patient data by funding an electronic medical records system that helps track patient progress, evaluate program effectiveness and facilitate detailed epidemiological studies.

Download PDF of this Project
Results Sources: Direct Relief International and Clinica Vivir con Diabetes
Results to Date

05/14/2012
MORE ON Diabetes Education in Bolivia
ADDITIONAL PROJECTS

Copyright © 2006, 2012 Abbott Fund. Abbott Park, Illinois, U.S.A.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company.